August 27, 2016 10:04 PM ET

Biotechnology

Company Overview of NGM Biopharmaceuticals, Inc.

Executive Profile

William J. Rieflin

Chief Executive Officer and Director, NGM Biopharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
56--

Background

Mr. William J. Rieflin, also known as Bill, has been the Chief Executive Officer of NGM Biopharmaceuticals, Inc. since October 5, 2010. Mr. Rieflin served as the President of Xenoport, Inc. since September 2004 and oversees its corporate development, human resources, legal and administrative functions. He served as Strategic Advisor at NGM Biopharmaceuticals, Inc. until October 5, 2010. He served as Secretary at Xenoport, Inc. From 1996 to 2004, Mr. Rieflin held various ...

Corporate Headquarters

630 Gateway Boulevard
South San Francisco, California 94080-7014

United States

Phone: 650-243-5555
Fax: 650-583-1646

Board Members Memberships

2010-Present
Chief Executive Officer and Director

Education

MBA
The University of Chicago Booth School of Business
JD
Stanford University Law school
BS
Cornell University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NGM Biopharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.